Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Immunogenicity And Safety Of Combined Intradermal Recombinant Hepatitis B With Bcg Vaccines At Birth.
Author: Carniel, E F
Morcillo, A M
Blotta, M H
Da Silva, M T N
Mazzola, T N
Antonio, M A R G M
Zanolli, M L
Netto, A Aranha
Higashi, H G
Raw, I
Vilela, M M S
Abstract: This randomized, prospective, non-inferiority study aimed to quantify anti-HBs titers induced by recombinant Hepatitis B vaccine from healthy infants vaccinated with combined Hepatitis B and Bacillus Calmette-Guérin (BCG) vaccines (HbsAg 10 microg plus BCG suspension 0.1mg) and compare them to titers obtained with separated vaccines. Infants were immunized at birth either with combined intradermal (ID) BCG and Hepatitis B or ID BCG alone and intramuscular (IM) Hepatitis B. Both groups received IM Hepatitis B at 1 and 6 months of age. After the third dose anti-HBs titers > or =10 IU/mL were observed in 99% of vaccinees and > or =1000 IU/mL in 71%. There were no adverse events in both groups. Combination of HbsAg with BCG as first dose did not modify the profile of the humoral immune response for Hepatitis B indicating safety and immunogenicity of this vaccine in newborn.
Subject: Bcg Vaccine
Hepatitis B
Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B Vaccines
Hepatitis B Virus
Immunization Schedule
Infant, Newborn
Injections, Intradermal
Prospective Studies
Vaccines, Combined
Vaccines, Synthetic
Citation: Vaccine. v. 26, n. 5, p. 647-52, 2008-Jan.
Rights: fechado
Identifier DOI: 10.1016/j.vaccine.2007.11.048
Date Issue: 2008
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_18155811.pdf151.68 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.